{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:02:24Z","timestamp":1770508944025,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T00:00:00Z","timestamp":1459728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ijrobp.2016.03.031","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T12:34:41Z","timestamp":1459168481000},"page":"1367-1377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["IDEAL-CRT: A Phase 1\/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II\/III Non-Small Cell Lung Cancer"],"prefix":"10.1016","volume":"95","author":[{"given":"David B.","family":"Landau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew T.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Bayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Counsell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Garcia-Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan V.","family":"Harden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon R.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne C.","family":"Illsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iftekhar","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Laurence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zafar","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Mayles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William Philip M.","family":"Mayles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Miles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6758-3816","authenticated-orcid":false,"given":"Nazia","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yenting","family":"Ngai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Spicer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Fenwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2016.03.031_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(97)06305-8","article-title":"Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomised multicentre trial. CHART Steering Committee","volume":"350","author":"Saunders","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ijrobp.2015.07.2284","article-title":"Radiation therapy intensification for solid tumors: A systematic review of randomized trials","volume":"93","author":"Yamoah","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib3","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer","volume":"28","author":"Auperin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib5","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1200\/JCO.2012.41.6677","article-title":"Hyperfractionated or accelerated radiotherapy in lung cancer: An individual patient data meta-analysis","volume":"30","author":"Mauguen","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib6","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1200\/JCO.2012.44.5064","article-title":"New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer","volume":"31","author":"Salama","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijrobp.2010.09.004","article-title":"Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: An analysis of the Radiation Therapy Oncology Group","volume":"82","author":"Machtay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib8","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.ijrobp.2007.11.028","article-title":"Radiation dose prescription for non-small cell lung cancer according to normal tissue dose constraints: An in silico clinical trial","volume":"71","author":"Van Baardwijk","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.radonc.2011.10.010","article-title":"Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study","volume":"102","author":"De Ruysscher","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib10","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/j.ejca.2012.04.014","article-title":"Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer","volume":"48","author":"Van Baardwijk","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.clon.2008.12.011","article-title":"Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: Opportunities for treatment improvement","volume":"21","author":"Fenwick","year":"2009","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib12","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1088\/0031-9155\/51\/22\/005","article-title":"On the dosimetric behaviour of photon dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations","volume":"51","author":"Kn\u00f6os","year":"2006","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-8140(03)00195-6","article-title":"Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: Re-evaluation of dose in normal lung tissue","volume":"69","author":"De Jaeger","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib14","series-title":"Basic Clinical Radiobiology","first-page":"126","article-title":"Dose-response relationships in radiotherapy","author":"Joiner","year":"2002"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0360-3016(00)01374-2","article-title":"A new approach to dose escalation in non-small-cell lung cancer","volume":"49","author":"Mehta","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib16","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.ijrobp.2014.08.348","article-title":"Global harmonization of quality assurance naming conventions in radiation therapy clinical trials","volume":"90","author":"Melidis","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib17","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/sim.721","article-title":"Sample size tables for exact single-stage phase II designs","volume":"20","author":"A'Hern","year":"2001","journal-title":"Stat Med"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib18","first-page":"CD002140","article-title":"Concurrent chemoradiotherapy in\u00a0non-small cell lung cancer","author":"O'Rourke","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.radonc.2013.08.017","article-title":"Severe late esophagus toxicity in NSCLC patients treated with IMRT and concurrent chemotherapy","volume":"108","author":"Chen","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib20","unstructured":"ASCO University. A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617. Available at: http:\/\/meetinglibrary.asco.org\/content\/82285?media=vm. Accessed June 1, 2015"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib21","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/S0167-8140(15)40239-7","article-title":"Can dose escalation be consistently carried out in a multi-centre trial? QA results for IDEAL-CRT and I-START trials","volume":"115","author":"Parsons","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2016.03.031_bib22","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.ejca.2014.07.009","article-title":"SOCCAR: A randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III non-small cell lung cancer and good performance status","volume":"50","author":"Maguire","year":"2014","journal-title":"Eur J Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301616003436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301616003436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T20:52:14Z","timestamp":1536871934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301616003436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0360301616003436"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2016.03.031","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IDEAL-CRT: A Phase 1\/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II\/III Non-Small Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2016.03.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}